Progress of the research on EMS/AHPNS in China: Vibrio - - PowerPoint PPT Presentation

progress of the research on ems ahpns in china vibrio
SMART_READER_LITE
LIVE PREVIEW

Progress of the research on EMS/AHPNS in China: Vibrio - - PowerPoint PPT Presentation

Progress of the research on EMS/AHPNS in China: Vibrio parahaemolyticus and suspected Yellowhead virus isolated from EMS/AHPNS cases Dr. Jie Huang Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences Isolation of V.


slide-1
SLIDE 1

Progress of the research on EMS/AHPNS in China: Vibrio parahaemolyticus and suspected Yellowhead virus isolated from EMS/AHPNS cases

  • Dr. Jie Huang

Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences

slide-2
SLIDE 2

Isolation of V. parahaemolyticus

Samples of suspected

EMS/AHPNS from Guangxi Province (E) in 2010.

Juvenile L. vannamei in

the second crop

Yellow to pale and

atrophy hepatopancreas

Mortality around 90%

Location of the reported cases of suspected EMS/AHPNS in 2010

slide-3
SLIDE 3

Isolation of V. parahaemolyticus

~2mm opaque,

raised, and smooth colonies on 2216E agar

Green colonies on

TCBS agar

G- rod-like cells with

  • ne end flagella
slide-4
SLIDE 4

Carbon source utilization by Biolog

Carbon source 6h 12h 18h Carbon source 6h 12h 18h Carbon source 6h 12h 18h Water — — — Cyclodextrin + + + Dextrin + + + Erythritol — — — D-fructose + + + L-fructose — — — D-melibiose — — — β-methyl-D-glycosidase + + + Allulose + + + Acetate — b b cis-Aconitic acid (aconitic acid) — — b Citrate — — — p-hydroxyphenylacetic acid — — — Itaconic acid — — — α-ketobutyrate — — — Bromosuccinic acid — B + Succinamicacid — — — Glucuronamide — b b L-histidine — — — Hydroxy-L–proline — + + L-leucine — — — Urocanic acid b b b Inosine + + + Uridine + + + Starch + + + Twain 40 + + + Twain 80 + + + D-galactose — + + Gentiobiose — — — α-D-glucose + + + D- raffinose — — — L-raffinose — — — D-sorbitol — — — Formate — — — D-galactonolactone — — — D-galacturonic acid — — — α-oxoglutarate — — — α-aminolevulinate — — — D,L-lactate + + + L-alanine — b — D-alanine — + + L-alanine — + + L-ornithine — — — L-phenylalanine — — — L-proline b + + Thymidine + + + Phenylethylamine — — — Butanediamine — — — N-acetyl - D galactosamine — — — N-acetyl-D–glucosamine + + + Adonitol — — — m-inositol — — — D-lactose — — — Lactulose — — — Sucrose — — — D-trehalose + + + Turanose — — — D-gluconate + + + D-glucosamine acid — — — D-gluconic acid — b + Malonate — — — Propionic acid — b + Quinate — — — L-alanyl-glycine — — — L-Asparagine + + + L-asparaginic acid + + + L-Pyroglutamate — — — D-serine — — — L-serine b + + 2-aminoethanol — — — 2,3-butanediol — — — Glycerol — + + L-arabinose b + + D-arabinose — — — D-cellose — — — Maltose + + + D-mannitol + + + D-mannose + + + Newtol — — + Methylpropanoyl b + + Monomethyl succinic acid — b b α-hydroxybutyrate — — — β-hydroxybutyrate — — — γ-hydroxybutyrate — — — D-glucaric acid — — — Sebacic acid — — — Succinic acid b + + L-glutamic acid — — + Ammonia acyl-L-aspartate — — — Ammonia acyl-L-glutamic acid b + + L-threonine b + + D,L-carnitine — — — γ-aminobutyric acid — — — D,L-α-phosphoglycerol — + + 1-phosphate glucose — + + Glucose-6-phosphate + + +

slide-5
SLIDE 5

Identification by Fatty acid and 16S rDNA

Fatty acid Percent Fatty acid Percent 12:0 aldehyde 0.09 18:1 ω7c 13.15 14:0 3OH/16:1 iso I 3.65 16:1 ω6c/16:1 ω7c 38.22 16:1 ω7c/16:1 ω6c 38.22 18:0 ante/18:2 ω6,9c 0.27 18:0 ante/18:2 ω6,9c 0.27 18:1 ω6c 13.15

AF388387Vibrio parahaemolyticus 20100612001 AF513447Vibrio alginolyticus AJ874352Vibrio natriegens X74691V.alginolyticus AY738129Vibrio campbellii AY911396Vibrio harveyi AY426981Vibrio ezurae AJ514917Vibrio fortis AJ310648Vibrio agarivorans AY292927Vibrio lentus AY069971Listonella anguillarum

68 36 28 35 77 87 55 67 63

Analysis of fatty acid of the bacterial cells Phylogenetic tree of the bacteria in 10 V. spp. by 16S rDNA sequence

slide-6
SLIDE 6

Challenge test

LD50 to L. vannamei

is 1.4x106 CFU/shrimp by injection

Days post-challenge

1 2 3 4 5 6 7

Survivals

10 20 30 40 50 2.5E+6 2.5E+5 2.5E+4 2.5E+3 2.5E+2 PBS

slide-7
SLIDE 7

Antibiotic resistence

Antibiotics Conc. (g/disc)

  • Inh. zone

(mm) Sens. Antibiotics Conc. (g/disc)

  • Inh. zone

(mm) Sens.

Cefalexin 30

  • R

Lomefloxacin 18

  • R

Cefazolin 30 11 I Norfloxacin 10 15 I Cefradine 30

  • R

Ofloxacin 5 11 R Ceftazidime 30 13 R Metronidazole 5 11 R Cefatrizine

  • 17

I Pipemidic acid 30 9 R Amikacin 30 13 R Rifampicin 5 16 R Gentamicin 10 10 R Novobiocin 30 13 I Neomycin 30 12 R Kanamycin 30 15 I Streptomycin 10 12 I Minocycline 30

  • R

Erythrocin 15 12 R Doxycycline 30

  • R

Clarithromycin 15 11 R Florfenicol 30 24 S Azithromycin 15 8 R SMZco 3.75/1.25 16 R Nalidixic acid 30 18 R

slide-8
SLIDE 8

Reference

The above results has been published:

Zhang B-C, Liu F, Bian H-H, Liu J, Pan L-Q,

Huang J. 2012. Isolation, identification, and pathogenicity analysis of a Vibrio parahaemolyticus strain from Litopenaeus

  • vannamei. (Chinese J.) Progress in Fishery

Sciences, 33(2): 56—62.

slide-9
SLIDE 9

Supporters for V. parahaemolyticus

  • Mr. Pang in Guangxi Province is

the earliest supporter since 2010 according to the above- mentioned results.

Experiences recommended:

Low salinity Water disinfection before stocking Bottom disinfection per 5—7 days Reduce water pH by probiotics Feed additive to reduce pH in gut Low organic fertilizer

All picture from Pang’s presentation

slide-10
SLIDE 10

Supporters for V. parahaemolyticus

  • Prof. Lai in Hainan University

concluded and supports that the pathogen is a Vibrio sp.

Green colonies on TCBS. Challenge with 2.5×104 CFU/mL

  • V. sp. in water caused L. vannamei

98% mortality in 10 days

1—3×106 CFU/g V. sp. in the

hepatopancreas of diseased shrimp

slide-11
SLIDE 11

Supporters for V. parahaemolyticus

  • Prof. He in Sun Yat-Sen Univ.

analyzed and concluded the pathogen may be V. parahaemolyticus and another bacteria

Successful control experience:

Bottom disinfection with particle

DBDMH, 1,3-Dibromino-5,5- dimethylhydantoin

slide-12
SLIDE 12

Histopathology of diseased shrimp

  • F. chinensis

samples collected in Hebei in 2012

  • L. Vannamei

samples collected in Guangdong in 2013

  • L. Vannamei

samples collected in Fujian in 2013

slide-13
SLIDE 13

Detection of infection with YHV by OIE standard

  • F. chinensis samples from Hebei in 2012
  • L. vannamei samples from Guangdong and Fujian in 2013

1st step RT-PCR 2nd step RT-PCR 1st step RT-PCR 2nd step RT-PCR

slide-14
SLIDE 14

Detection of YHV by improved rapid RT-LAMP Kit for YHV

Samples from Hebei 2012 Samples from Guangdong 2013 Samples from Fujian 2013

slide-15
SLIDE 15

Alignment between the sequences of the products of YHV detections and that of YHV1992 and YHV 1995

Source Length (bp) Query sequence Score Query cover Max identity Similarity YHV_AHPNS_hb201 2 KF278563 748 YHV1992 FJ848673.1 952 100% 87% 87% YHV_AHPNS_hb201 2 KF278563 228 YHV1995 FJ848674.1 304 100% 89% 89% YHV_AHPNS_fj2013 KF278565 226 YHV1995 FJ848674.1 295 96% 90% 86.4% YHV_AHPNS_gd201 3 KF278564 229 YHV1995 FJ848674.1 268 85% 90% 76.5%

slide-16
SLIDE 16

Phylogenetic tree of the YHV RT-PCR products and the relevant sequences of YHV/GAV

The product

  • f the first

step of the nested RT- PCR of the sample from Hebei 2012 The products

  • f the second

step of the nested RT- PCR of the 3 samples

slide-17
SLIDE 17

Phylogenetic tree of the YHV genotypes

By nucleocapsid protein By genome sequence

YHV genotype1

slide-18
SLIDE 18

Challenge tests

20 40 60 80 100 100 200 300 Cumulative mortality (%) Hours post-challenge Unfiltered Filtered Control

  • L. vannamei challenged with unfiltered

and 0.45µm filtered homogenate

  • L. vannamei and P. clarkii challenged

with 0.45µm filtered homogenate

a a a a a a a a a a a a a a a b b c c c c c c c c c c c a b b b b b b b b b b b b b 20 40 60 80 100 2 4 6 8 10 12 14 Cumulative mortality (%) Days post challenge YHV - L. vannamei YHV - P. clarkii PBS - P. clarkii PBS - L. vannamei

slide-19
SLIDE 19

Challenged with filtered homogenate Challenged with filtered homogenate Challenged with unfiltered homogenate Challenged with unfiltered homogenate Epithelium separates from tubule Epithelium separates from tubule membrane membrane Disfunction of the cells in hepatopancreas Disfunction of the cells in hepatopancreas Atrophy in the tubule epithelium Atrophy in the tubule epithelium Epithelium separates from tubule Epithelium separates from tubule membrane membrane Disfunction of the cells in hepatopancreas Disfunction of the cells in hepatopancreas Tubule membrane degradation Tubule membrane degradation Adhesion loss between tubule epithelial Adhesion loss between tubule epithelial cells cells Bacterial infection Bacterial infection

slide-20
SLIDE 20

Virus targeting tissue

Fluorescein labeled RT-PCR

products as the probe.

Fluorescent signals detected in

HP epithelium, without relating to any visible inclusions under normal microscopy

Similar lesions containing

spherical virus-like particles

  • bserved by TEM

The morphology of the virus-like

particles is different from YHV

slide-21
SLIDE 21

Major Diseases in Farmed Shrimp Disease in farms Disease in farms Pathogen Pathogen

White spot / White spot / reddish body reddish body disease disease

WSSV WSSV

Slow Slow growth

growth /

/ hatchery mortality hatchery mortality

Covert mortality Covert mortality EMS / AHPNS EMS / AHPNS IHHNV IHHNV YHV YHV

  • V. parahaemolyticus

? ?

slide-22
SLIDE 22

Covert disease and EMS/AHPNS

Covert disease before 2010

Continual deaths with a higher cumulative mortality

about 60—80%

More cases around 30—60 days post-stocking Rare pond-side cases Pale or yellow hepatopancreas with some atrophy

Covert disease after 2010

Original covert disease EMS/AHPNS

slide-23
SLIDE 23
  • V. parahaemolyticus
  • V. parahaemolyticus

Poor culture condition Poor culture condition

slide-24
SLIDE 24

DGGE analysis of bacterial community in biofloc cultured M. japonicus

30% 60% DGGE profile and its clustering analysis of amplified 16S rRNA-V3 gene fragments of bacterial

  • communities. (a) DGGE profile; (b) clustering analysis of DGGE profile; Lane SI, SII, and SIII, bio-

floc treatment ponds; Lane CI, CII, and CIII, relative control ponds (a) (b)

slide-25
SLIDE 25

DGGE bands sequencing results

Proteobacterium (43.89±4.42)% Bacillus sp. (27.71±2.83)% Actinobacterium (8.16±4.12)% Roseobacter sp. (1.53±2.66)% Cytophaga sp. (0.97±3.92)% Proteobacterium (29.16±4.07)% Vibrio sp. (22.65±4.49)% Paracoccus sp. (5.45±2.57)% Cytophaga sp. (3.90±5.64)% Photobacterium sp. (1.53±2.64)% Halomonas sp. (1.45±2.51)%

90 80 70 60 50 40 30 20 10 Bio-floc treatment Relative control

Pseudoalteromonas sp. (11.02±6.22)%

slide-26
SLIDE 26

A trial for the probiotic enhanced biofloc technology for high density farming of shrimp

10 20 30 40 50 60 70 80 A B C Survival (%) 2 4 6 8 10 12 14 A B C Average body weight (g) 1 2 3 4 5 6 A B C Feed Index 0.0 0.5 1.0 1.5 2.0 2.5 3.0 A B C Production (kg/m2)

Culture species: L. vannamei; salinity: 1.6~2.2; pond size: 23m2; Stocking density: 300/m2 ; stocking size: (1.35 ±0.31) cm; Culture period: 83 days. Group A. B. subtilis used for the probiotics; Group B. A local isolated B. sp. used for the probiotics; Group C. no biofloc technology used.

slide-27
SLIDE 27

Disease Course in a Shrimp Farm

11% total ponds diseased 4% polyculture ponds diseased 15% single culture ponds diseased

slide-28
SLIDE 28

Recommended prevention strategies

Early detection and quarantine

Rapid diagnostic kit for on-site use. Bloodstock, egg, or postlarva quarantine Disease surveillance

Disinfection

Disinfection before stocking Regular bottom disinfection during culture stage

Probiotics and biofloc technology

Probiotics for feed and environment use. Microorganism enhanced biofloc technology.

Polyculture technology

slide-29
SLIDE 29

THANKS FOR YOUR ATTENTION!

Acknowledgements: Thanks FAO invite and support me to participate the workshop. This work is supported by the Special Fund for Agro-scientific Research in the Public Interest “Research and demonstration of the rapid diagnosis and biological control technology for the viral diseases in farmed shrimp” (Grant: 201103034) and China Agriculture Research System “the tasks for diseases control scientists in the Farmed Shrimp Research System” (Grant: CARS-47).